JPWO2021055752A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021055752A5
JPWO2021055752A5 JP2022517391A JP2022517391A JPWO2021055752A5 JP WO2021055752 A5 JPWO2021055752 A5 JP WO2021055752A5 JP 2022517391 A JP2022517391 A JP 2022517391A JP 2022517391 A JP2022517391 A JP 2022517391A JP WO2021055752 A5 JPWO2021055752 A5 JP WO2021055752A5
Authority
JP
Japan
Prior art keywords
polymer
integer
pharmaceutical composition
polymer according
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022517391A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022548698A (ja
JP2022548698A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/051499 external-priority patent/WO2021055752A1/en
Publication of JP2022548698A publication Critical patent/JP2022548698A/ja
Publication of JPWO2021055752A5 publication Critical patent/JPWO2021055752A5/ja
Publication of JP2022548698A5 publication Critical patent/JP2022548698A5/ja
Priority to JP2024202452A priority Critical patent/JP2025019142A/ja
Withdrawn legal-status Critical Current

Links

JP2022517391A 2019-09-20 2020-09-18 ベンゾオキサボロールポリマーおよび使用方法 Withdrawn JP2022548698A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024202452A JP2025019142A (ja) 2019-09-20 2024-11-20 ベンゾオキサボロールポリマーおよび使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962903332P 2019-09-20 2019-09-20
US62/903,332 2019-09-20
PCT/US2020/051499 WO2021055752A1 (en) 2019-09-20 2020-09-18 Benzoxaborole polymers and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024202452A Division JP2025019142A (ja) 2019-09-20 2024-11-20 ベンゾオキサボロールポリマーおよび使用方法

Publications (3)

Publication Number Publication Date
JP2022548698A JP2022548698A (ja) 2022-11-21
JPWO2021055752A5 true JPWO2021055752A5 (https=) 2023-09-28
JP2022548698A5 JP2022548698A5 (https=) 2023-09-28

Family

ID=74884685

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022517391A Withdrawn JP2022548698A (ja) 2019-09-20 2020-09-18 ベンゾオキサボロールポリマーおよび使用方法
JP2024202452A Pending JP2025019142A (ja) 2019-09-20 2024-11-20 ベンゾオキサボロールポリマーおよび使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024202452A Pending JP2025019142A (ja) 2019-09-20 2024-11-20 ベンゾオキサボロールポリマーおよび使用方法

Country Status (4)

Country Link
US (1) US20220396651A1 (https=)
EP (1) EP4041740A4 (https=)
JP (2) JP2022548698A (https=)
WO (1) WO2021055752A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021055759A1 (en) 2019-09-20 2021-03-25 Glyscend, Inc. Substituted phenyl boronic acid containing polymers and methods of use
WO2025122491A1 (en) * 2023-12-04 2025-06-12 Aviko Radiopharmaceuticals, Llc Fused bicyclic aryl compounds for boron neutron capture therapy
WO2025144975A1 (en) * 2023-12-28 2025-07-03 Aviko Radiopharmaceuticals, Llc Fused bicyclic aryl compounds for boron neutron capture therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3413898B2 (ja) * 1993-09-14 2003-06-09 満 明石 高分子化合物およびその製造方法
AU2003291567A1 (en) * 2002-11-19 2004-06-15 Genzyme Corporation Polymeric boronic acid derivatives as lipase inhibitors
EP2226075A1 (en) * 2007-11-22 2010-09-08 The University of Tokyo Material for preventing tissue adhesion and material for preventing joint contracture
WO2017024237A1 (en) * 2015-08-06 2017-02-09 The Johns Hopkins University Composition and method for treatment of metabolic disorders
WO2017061435A1 (ja) * 2015-10-06 2017-04-13 国立研究開発法人物質・材料研究機構 ビニルアルコール樹脂機能化方法並びにビニルアルコール樹脂機能化剤
JP6630761B2 (ja) * 2018-03-06 2020-01-15 株式会社竹村製作所 樹脂管用継手
CN108478779B (zh) * 2018-04-12 2021-06-04 南京邮电大学 一种肿瘤靶向纳米药物及其制备方法和用途

Similar Documents

Publication Publication Date Title
EP4125896B1 (en) Treatment of type 2 diabetes with 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl} piperidin-1-yl)methyl]-1-[(2s)-oxetan-2-ylmethyl]-1h-benzimidazole-6-carboxylic acid or a pharmaceutically salt thereof
JP6581625B2 (ja) 代謝障害を治療するための組成物および方法
CN110051638B (zh) 包含双胍的延迟释放组合物
JP2023096079A (ja) 化合物の製剤およびそれらの使用
JP2013520561A5 (https=)
JP2009504599A (ja) Dpp−iv阻害剤を含有する医薬組成物
JP2014504639A (ja) アミン化合物を含む医薬製剤
Yoon et al. Pharmacokinetic and dose‐finding studies on efpeglenatide in patients with type 2 diabetes
US20240216476A1 (en) Combination of bitter receptor agonist and gut-signaling compound
Huang et al. Gut hormone multi-agonists for the treatment of type 2 diabetes and obesity: advances and challenges
JPWO2021055752A5 (https=)
US9815777B2 (en) Metformin salts to treat Type2 diabetes
JPWO2021055759A5 (https=)
Agrawal et al. Novel serine protease dipeptidyl peptidase IV inhibitor: alogliptin
US20140302150A1 (en) Dpp-iv inhibitor formulations
JP2023145581A (ja) インターロイキン-23受容体のペプチド阻害剤の組成物
WO2016066668A1 (en) Pharmaceutical combinations of vildagliptin and ppar agonists
JPWO2022049310A5 (https=)
JPWO2020061430A5 (https=)
US20230028715A1 (en) Il-31 modulators for treating fxr-induced pruritis
HK40012109B (zh) 包含双胍的延迟释放组合物
KR20220165346A (ko) 에보글립틴의 안정성이 개선된 제제
JP2011510974A (ja) HMG−CoA還元酵素阻害剤の調節放出製剤
HK40021394A (en) Compositions and methods for treating metabolic disorders
JPWO2003099332A1 (ja) Atpクエン酸リアーゼの発現抑制用医薬組成物及びその使用